Annual SGA
$4.90 M
+$842.40 K+20.74%
December 31, 2023
Summary
- As of February 8, 2025, LPCN annual SGA is $4.90 million, with the most recent change of +$842.40 thousand (+20.74%) on December 31, 2023.
- During the last 3 years, LPCN annual SGA has fallen by -$3.34 million (-40.53%).
- LPCN annual SGA is now -52.76% below its all-time high of $10.38 million, reached on December 31, 2016.
Performance
LPCN SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly SGA
$1.05 M
-$462.20 K-30.66%
September 30, 2024
Summary
- As of February 8, 2025, LPCN quarterly SGA is $1.05 million, with the most recent change of -$462.20 thousand (-30.66%) on September 30, 2024.
- Over the past year, LPCN quarterly SGA has dropped by -$89.40 thousand (-7.88%).
- LPCN quarterly SGA is now -76.23% below its all-time high of $4.40 million, reached on March 31, 2016.
Performance
LPCN Quarterly SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM SGA
-$796.92 M
-$4.06 M-0.51%
September 30, 2024
Summary
- As of February 8, 2025, LPCN TTM SGA is -$796.92 million, with the most recent change of -$4.06 million (-0.51%) on September 30, 2024.
- Over the past year, LPCN TTM SGA has dropped by -$801.83 million (-16347.51%).
- LPCN TTM SGA is now -974134.72% below its all-time high of -$81.80 thousand.
Performance
LPCN TTM SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Selling, General & Administrative Expenses Formula
SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development
LPCN Selling, General & Administrative Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +20.7% | -7.9% | -10000.0% |
| 3 y3 years | -40.5% | -27.4% | -10000.0% |
| 5 y5 years | -7.3% | -27.4% | -10000.0% |
LPCN Selling, General & Administrative Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -8.0% | +20.7% | -33.7% | +30.8% | -12.4% | at low |
| 5 y | 5-year | -40.5% | +20.7% | -55.0% | +30.8% | -36.3% | at low |
| alltime | all time | -52.8% | >+9999.0% | -76.2% | +188.5% | <-9999.0% | at low |
Lipocine Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $1.05 M(-30.7%) | $5.26 M(+0.0%) |
| Jun 2024 | - | $1.51 M(-4.3%) | $5.26 M(+1.3%) |
| Mar 2024 | - | $1.58 M(+38.9%) | $5.19 M(+5.9%) |
| Dec 2023 | $4.90 M(+20.7%) | $1.13 M(+8.8%) | $4.90 M(+5.2%) |
| Sep 2023 | - | $1.04 M(-27.6%) | $4.66 M(+5.5%) |
| Jun 2023 | - | $1.44 M(+11.9%) | $4.42 M(+7.6%) |
| Mar 2023 | - | $1.29 M(+44.6%) | $4.11 M(+1.1%) |
| Dec 2022 | $4.06 M(-23.8%) | $890.30 K(+11.4%) | $4.06 M(-3.7%) |
| Sep 2022 | - | $798.90 K(-29.3%) | $4.22 M(-9.1%) |
| Jun 2022 | - | $1.13 M(-9.2%) | $4.64 M(-7.9%) |
| Mar 2022 | - | $1.24 M(+18.7%) | $5.04 M(-5.4%) |
| Dec 2021 | $5.33 M(-35.4%) | $1.05 M(-14.2%) | $5.33 M(-19.3%) |
| Sep 2021 | - | $1.22 M(-19.9%) | $6.60 M(-9.2%) |
| Jun 2021 | - | $1.53 M(-0.5%) | $7.27 M(-5.6%) |
| Mar 2021 | - | $1.53 M(-33.9%) | $7.70 M(-6.7%) |
| Dec 2020 | $8.25 M(+47.4%) | $2.32 M(+23.0%) | $8.25 M(+9.5%) |
| Sep 2020 | - | $1.89 M(-3.4%) | $7.53 M(+6.5%) |
| Jun 2020 | - | $1.95 M(-6.3%) | $7.07 M(+8.7%) |
| Mar 2020 | - | $2.09 M(+29.7%) | $6.51 M(+16.2%) |
| Dec 2019 | $5.60 M(+5.8%) | $1.61 M(+12.6%) | $5.60 M(+12.4%) |
| Sep 2019 | - | $1.43 M(+2.9%) | $4.98 M(+11.1%) |
| Jun 2019 | - | $1.39 M(+17.9%) | $4.48 M(-6.2%) |
| Mar 2019 | - | $1.18 M(+18.8%) | $4.78 M(-9.7%) |
| Dec 2018 | $5.29 M | $989.50 K(+6.4%) | $5.29 M(-33.3%) |
| Sep 2018 | - | $930.10 K(-44.7%) | $7.93 M(-18.4%) |
| Jun 2018 | - | $1.68 M(-0.3%) | $9.72 M(-3.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2018 | - | $1.69 M(-53.6%) | $10.08 M(-1.3%) |
| Dec 2017 | $10.21 M(-1.6%) | $3.64 M(+33.7%) | $10.21 M(+28.9%) |
| Sep 2017 | - | $2.72 M(+33.7%) | $7.92 M(+20.1%) |
| Jun 2017 | - | $2.03 M(+11.4%) | $6.60 M(-15.5%) |
| Mar 2017 | - | $1.83 M(+35.9%) | $7.81 M(-24.8%) |
| Dec 2016 | $10.38 M(+78.9%) | $1.34 M(-3.7%) | $10.38 M(-5.4%) |
| Sep 2016 | - | $1.39 M(-57.1%) | $10.97 M(-2.7%) |
| Jun 2016 | - | $3.25 M(-26.1%) | $11.27 M(+23.3%) |
| Mar 2016 | - | $4.40 M(+127.8%) | $9.14 M(+57.6%) |
| Dec 2015 | $5.80 M(+16.0%) | $1.93 M(+13.5%) | $5.80 M(+15.1%) |
| Sep 2015 | - | $1.70 M(+52.4%) | $5.04 M(+19.7%) |
| Jun 2015 | - | $1.12 M(+5.7%) | $4.21 M(+1.9%) |
| Mar 2015 | - | $1.06 M(-9.8%) | $4.13 M(-17.4%) |
| Dec 2014 | $5.00 M(+37.6%) | $1.17 M(+34.2%) | $5.00 M(+2.8%) |
| Sep 2014 | - | $871.80 K(-15.8%) | $4.87 M(-6.0%) |
| Jun 2014 | - | $1.04 M(-46.2%) | $5.18 M(+24.9%) |
| Mar 2014 | - | $1.92 M(+86.0%) | $4.14 M(+86.4%) |
| Dec 2013 | $3.64 M(+4702.8%) | $1.03 M(-12.5%) | $2.22 M(>+9900.0%) |
| Sep 2013 | - | $1.18 M(>+9900.0%) | $7200.00(-101.0%) |
| Jun 2013 | - | $3100.00(-3.1%) | -$707.50 K(+8.9%) |
| Mar 2013 | - | $3200.00(-100.3%) | -$649.70 K(+0.2%) |
| Dec 2012 | $75.70 K(+1414.0%) | -$1.18 M(-352.8%) | -$648.50 K(-221.8%) |
| Sep 2012 | - | $467.20 K(+667.2%) | $532.50 K(+715.5%) |
| Jun 2012 | - | $60.90 K(+1284.1%) | $65.30 K(+1384.1%) |
| Mar 2012 | - | $4400.00 | $4400.00 |
| Dec 2011 | $5000.00 | - | - |
FAQ
- What is Lipocine annual SGA?
- What is the all time high annual SGA for Lipocine?
- What is Lipocine annual SGA year-on-year change?
- What is Lipocine quarterly SGA?
- What is the all time high quarterly SGA for Lipocine?
- What is Lipocine quarterly SGA year-on-year change?
- What is Lipocine TTM SGA?
- What is the all time high TTM SGA for Lipocine?
- What is Lipocine TTM SGA year-on-year change?
What is Lipocine annual SGA?
The current annual SGA of LPCN is $4.90 M
What is the all time high annual SGA for Lipocine?
Lipocine all-time high annual SGA is $10.38 M
What is Lipocine annual SGA year-on-year change?
Over the past year, LPCN annual SGA has changed by +$842.40 K (+20.74%)
What is Lipocine quarterly SGA?
The current quarterly SGA of LPCN is $1.05 M
What is the all time high quarterly SGA for Lipocine?
Lipocine all-time high quarterly SGA is $4.40 M
What is Lipocine quarterly SGA year-on-year change?
Over the past year, LPCN quarterly SGA has changed by -$89.40 K (-7.88%)
What is Lipocine TTM SGA?
The current TTM SGA of LPCN is -$796.92 M
What is the all time high TTM SGA for Lipocine?
Lipocine all-time high TTM SGA is -$81.80 K
What is Lipocine TTM SGA year-on-year change?
Over the past year, LPCN TTM SGA has changed by -$801.83 M (-16347.51%)